# PRDGX (PRDGX)

> Source: Nexqual · https://nexqual.com/PRDGX · data as of 2026-10-24 00:08 UTC · cite as "Nexqual, PRDGX (PRDGX), nexqual.com/PRDGX" · informational, not investment advice.

**Price:** USD 90.47 (-0.73% on the day) · last close of Oct 23, 2026; US market closed, not a live price. Prev close 90.47 · day 90.47–90.47 · 52w 79.33–92 · market cap null · NAS

## Key facts
- Total return with dividends: 1Y +13.3% vs S&P 500 +13.4%; 5Y +55.0% vs S&P 500 +76.9%.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-24) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | +13.3% | +55.0% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | +13.3% | +9.2% |
| Volatility (annualized) | 9.7% | 13.6% |
| Max drawdown | -7.3% (Feb 2026→Mar 2026) | -18.9% (Dec 2021→Sep 2022) |

## Peers
TRBCX (T. Rowe Price Blue Chip Growth ) USD 207.91 -0.00% · TRVLX (T. Rowe Price Value Fund, Inc.) USD 58.4 -0.00% · PRHSX (T. Rowe Price Health Sciences F) USD 97.06 +0.00% · PRDSX (T. Rowe Price QM U.S. Small-Cap) USD 48.55 +0.00% · PRWCX (T. Rowe Price Capital Appreciat) USD 38.98 +0.00%

## More
Full page: https://nexqual.com/PRDGX · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

